AnaptysBio, Inc. (ANAB)
51.25
+0.88
(+1.75%)
USD |
NASDAQ |
Jun 08, 14:32
AnaptysBio Market Cap : 1.488B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 121.34M |
| Vanda Pharmaceuticals, Inc. | 358.41M |
| Precision BioSciences, Inc. | 186.19M |
| Amgen, Inc. | 185.97B |
| BioCryst Pharmaceuticals, Inc. | 2.117B |
Market Cap Related Metrics
| PS Ratio | 6.498 |
| Price to Book Value | 116.72 |
| Price to Free Cash Flow | 342.51 |
| Price | 51.25 |
| Earnings Yield | -2.11% |
| Operating PE Ratio | 37.01 |